Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

2.070

-0.035 (-1.66%)

At close: Nov 6, 2026, 4:00 PM EST

2.100

+0.030 (1.45%)

After-hours: Nov 6, 2026, 7:41 PM EST

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	69.36	64.64	44.51	27.17	20.29	28.02
Cash & Short-Term Investments	69.36	64.64	44.51	27.17	20.29	28.02
Cash Growth	8.14%	45.22%	63.80%	33.93%	-27.59%	69.84%
Receivables	6.84	9.74	7.77	5.23	8.48	5.23
Inventory	20.52	20.42	9.19	14.53	14.68	13.6
Prepaid Expenses	3.34	1.31	2.48	2.45	2.97	1.86
Restricted Cash	0.15	0.15	0.15	0.15	0.15	0.2
Other Current Assets	-	0.54	-	-	-	-
Total Current Assets	100.22	96.81	64.1	49.53	46.57	48.91
Property, Plant & Equipment	2.87	3.52	3.45	4.54	6.32	7.36
Other Intangible Assets	5.14	5.66	0.36	0.51	0.67	0.86
Other Long-Term Assets	0.47	0.43	0.37	0.38	0.5	0.72
Total Assets	108.69	106.41	68.28	54.96	54.06	57.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	11.5	10.8	8.53	10.23	9.68	10.42
Accrued Expenses	3.93	7.72	7.82	9.49	7.34	6.48
Current Portion of Leases	0.8	1	0.99	0.7	0.7	0.55
Current Unearned Revenue	0.14	0.4	0.61	0.2	0.16	0.16
Other Current Liabilities	0.54	-	-	-	-	-
Total Current Liabilities	16.91	19.92	17.95	20.62	17.87	17.61
Long-Term Leases	1.28	1.82	1.66	2.58	3.56	4.15
Long-Term Unearned Revenue	2.16	2.67	2.58	3.31	3.96	4.35
Other Long-Term Liabilities	5.27	5.47	-	-	-	-
Total Liabilities	25.62	29.87	22.18	26.51	25.39	26.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.08	0.08	0.08	0.08	0.07	0.07
Additional Paid-In Capital	241.42	240.99	227.93	218.85	214.09	200.61
Retained Earnings	-158.42	-164.53	-181.91	-190.46	-185.49	-168.95
Comprehensive Income & Other	-0	-0.01	-0	-0	-0	-0
Shareholders' Equity	83.07	76.53	46.09	28.46	28.67	31.73
Total Liabilities & Equity	108.69	106.41	68.28	54.96	54.06	57.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.08	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	67.28	61.82	41.86	23.9	16.03	23.32
Net Cash Growth	10.14%	47.69%	75.16%	49.05%	-31.24%	56.91%
Net Cash Per Share	0.81	0.72	0.54	0.32	0.23	0.35
Filing Date Shares Outstanding	79.36	80.25	77.92	75.48	75.02	68.49
Total Common Shares Outstanding	79.2	79.88	77.5	75.15	74.75	68.31
Working Capital	83.31	76.89	46.15	28.91	28.7	31.29
Book Value Per Share	1.05	0.96	0.59	0.38	0.38	0.46
Tangible Book Value	77.94	70.87	45.74	27.95	28	30.87
Tangible Book Value Per Share	0.98	0.89	0.59	0.37	0.37	0.45
Machinery	-	3.54	3.97	4.26	4.05	4.3
Construction In Progress	-	0.05	0.09	0.01	0.17	0.09
Leasehold Improvements	-	2.21	2.21	2.15	2.06	2.39